½ÃÀ庸°í¼­
»óǰÄÚµå
1631175

Àå±â º¸Á¸ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : º¸Á¸¾×º°, Àå±â À¯Çüº°, º¸Á¸ ±â¼úº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Organ Preservation Market Size, Share & Trends Analysis Report By Solution (University Of Wisconsin (UW), Custodiol HTK, Perfadex), By Organ Type, By Preservation Technique, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àå±â º¸Á¸ ½ÃÀå ¼ºÀå°ú µ¿Çâ

±×·£µå ºä ¸®¼­Ä¡(Grand View Research, Inc.)ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è Àå±â º¸Á¸ ½ÃÀåÀº 2025-2030³â µ¿¾È 6.5%ÀÇ CAGRÀ» º¸À̸ç 2030³â±îÁö 4¾ï 1,170¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³ëÀÎ Àα¸ÀÇ Áõ°¡, Àå±â ±âÁõÀ» Àå·ÁÇÏ´Â ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡, Àü ¼¼°èÀûÀ¸·Î Àå±â ºÎÀü »ç·Ê°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î Àå±â ºÎÀü »ç·Ê°¡ Áõ°¡Çϰí Àå±â ÀÌ½Ä ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÏ´Â °ÍÀº ¿¹Ãø ±â°£ µ¿¾È Àå±â º¸Á¸ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹ º¸°Çº¹ÁöºÎ°¡ 2019³â ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, ±¹³»¿¡¼­´Â ¾à 4¸¸ °ÇÀÇ Àå±â ÀÌ½Ä ¼ö¼úÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ¶ÇÇÑ, 2018-2019³â±îÁö ¾à 8.7%ÀÇ Àå±â ÀÌ½Ä ¼ö¼úÀÌ Áõ°¡ÇÑ °ÍÀ¸·Î º¸°íµÇ¾ú½À´Ï´Ù.

¸¶Âù°¡Áö·Î, À¯·´À§¿øÈ¸°¡ 2018³â ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é À¯·´¿¡¼­ ¾à 34,000°ÇÀÇ Àå±â À̽ÄÀÌ ÀÌ·ç¾îÁ³À¸¸ç, ±× Áß ½ÅÀå À̽ÄÀº 21,227°Ç, °£ À̽ÄÀº 7,940°Ç, ½ÉÀå À̽ÄÀº 2,287°Ç, Æó À̽ÄÀº 1,980°ÇÀ¸·Î Áý°èµÆ½À´Ï´Ù. Àå±â ±âÁõÀÚ ¼öÀÇ Áõ°¡µµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, ¹Ì±¹ º¸°Çº¹ÁöºÎ°¡ 2019³â¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2018-2019³â¿¡ »ç¸ÁÇÑ ±âÁõÀÚÀÇ ºñÀ²ÀÌ 10.7% Áõ°¡ÇßÀ¸¸ç, 2019³â¿¡´Â 7,400°Ç¿¡ °¡±î¿î »ýü ±âÁõÀÚ À̽ÄÀÌ ±â·ÏµÇ¾ú½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ »ç·Ê´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àå±â º¸Á¸ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • À§½ºÄܽŴëÇб³(UW)°¡ 2024³â 36.0%ÀÇ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, UWÀÇ ¼Ö·ç¼ÇÀº ½ÅÀå, °£ µî Àå±âÀÇ º¸Á¸ ±â°£À» Å©°Ô ¿¬ÀåÇß½À´Ï´Ù.
  • ½ÅÀåÀº ESRD ¹ßº´·ü Áõ°¡¿Í ´ç´¢º´, °íÇ÷¾Ð µî ¸¸¼ºÁúȯ¿¡ ÈûÀÔ¾î 2024³â 34.5%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ï´Ù.
  • Á¤Àû Àú¿Â ÀúÀå ºÎ¹®Àº 2024³â 45.1%ÀÇ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â 50³â ÀÌ»ó Ç¥ÁØÀÌ µÇ¾î¿Â SCS ÀúÀå ±â¼úÀÇ Æí¸®ÇÔ°ú È¿°ú¿¡ ±âÀÎÇÕ´Ï´Ù.
  • ºÏ¹Ì Àå±â º¸Á¸ ½ÃÀåÀº 2024³â 45.3%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àå±â º¸Á¸ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå Àå±â º¸Á¸ ½ÃÀå : º¸Á¸¾×º° ºñÁî´Ï½º ºÐ¼®

  • º¸Á¸¾× ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • º¸Á¸¾× ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, º¸Á¸¾×º°, 2018-2030³â
  • À§½ºÄܽŠ´ëÇÐ(UW)
  • Ä¿½ºÅäµð¿Ã HTK
  • ÆÛÆÄµ¦½º
  • ±âŸ

Á¦5Àå Àå±â º¸Á¸ ½ÃÀå : Àå±â À¯Çüº° ºñÁî´Ï½º ºÐ¼®

  • Àå±â À¯Çü ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • Àå±â À¯Çü ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, Àå±â À¯Çüº°, 2018-2030³â
  • ½ÅÀå
  • °£
  • Æó
  • ½ÉÀå
  • ±âŸ

Á¦6Àå Àå±â º¸Á¸ ½ÃÀå : º¸Á¸ ±â¼úº° ºñÁî´Ï½º ºÐ¼®

  • º¸Á¸ ±â¼ú ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • º¸Á¸ ±â¼ú ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, º¸Á¸ ±â¼úº°, 2018-2030³â
  • Á¤Àû ³ÃÀå º¸°ü
  • Àúü¿Â ¸Ó½Å °ü·ù
  • »ó¿Â ±â°è °ü·ù
  • ±âŸ

Á¦7Àå Àå±â º¸Á¸ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • Âü¿©ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • XVIVO
    • TransMedics, Inc.
    • 21st Century Medicine
    • Bridge to Life Ltd.
    • Preservation Solutions, Inc.
    • Global Transplant Solutions
    • Organ Recovery Systems
    • CryoLife, Inc.(Artivion, Inc)
    • Paragonix Technologies, Inc(Getinge)
ksm 25.03.07

Organ Preservation Market Growth & Trends:

The global organ preservation market is expected to reach USD 411.7 million by 2030, exhibiting a CAGR of 6.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing geriatric population, rising initiatives towards encouraging organ donation, and increasing cases of organ failure across the globe are the key factors driving the growth.

Increasing cases of organ failure across the globe and rising number of organ transplantation procedures are the key drivers impacting the growth of the market for organ preservation over the forecast period. According to the report published by the U.S. Department of Health and Human Services in 2019, around 40,000 organ transplantation procedures were performed in the country. It also reported that around 8.7% of organ transplantation procedure increased from 2018 to 2019.

Similarly, as per the report published by the European Commission in 2018, around 34,000 organ transplantations were performed in Europe, of which; the numbers of kidney transplants, liver transplants, heart transplants, and lung transplants were 21,227, 7,940, 2,287, and 1,980, respectively. An increase in the number of organ donors is also expected to positively impact the market.

For instance, as per the report published by the U.S. Department of Health and Human Services in 2019, the rate of deceased donors increased 10.7% from 2018 to 2019 in the U.S. and almost 7,400 living donor transplants were recorded in 2019. Therefore, such instances are expected to positively influence the market, thereby propelling the market growth.

Organ Preservation Market Report Highlights:

  • University of Wisconsin (UW) dominated the market and accounted for a share of 36.0% in 2024. The UW solution greatly extended preservation durations for organs such as kidneys and livers.
  • Kidneys led the market with a revenue share of 34.5% in 2024, supported by the rising incidence of ESRD and chronic conditions such as diabetes and hypertension.
  • The static cold storage segment held the largest share of 45.1% in 2024, attributed to the simplicity and effectiveness of the SCS preservation technique, which has been standard for over 50 years.
  • North America organ preservation market dominated the global market with a revenue share of 45.3% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Solution
    • 1.2.2. Organ Type
    • 1.2.3. Preservation Technique
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Organ Preservation Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Organ Preservation Market: Solution Business Analysis

  • 4.1. Solution Market Share, 2024 & 2030
  • 4.2. Solution Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2018 to 2030 (USD Million)
  • 4.4. University of Wisconsin (UW)
    • 4.4.1. University of Wisconsin (UW) Market, 2018 - 2030 (USD Million)
  • 4.5. Custodiol HTK
    • 4.5.1. Custodiol HTK Market, 2018 - 2030 (USD Million)
  • 4.6. Perfadex
    • 4.6.1. Perfadex Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Organ Preservation Market: Organ Type Business Analysis

  • 5.1. Organ Type Market Share, 2024 & 2030
  • 5.2. Organ Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Organ Type, 2018 to 2030 (USD Million)
  • 5.4. Kidneys
    • 5.4.1. Kidneys Market, 2018 - 2030 (USD Million)
  • 5.5. Liver
    • 5.5.1. Liver Market, 2018 - 2030 (USD Million)
  • 5.6. Lung
    • 5.6.1. Lung Market, 2018 - 2030 (USD Million)
  • 5.7. Heart
    • 5.7.1. Heart Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Organ Preservation Market: Preservation Technique Business Analysis

  • 6.1. Preservation Technique Market Share, 2024 & 2030
  • 6.2. Preservation Technique Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Preservation Technique, 2018 to 2030 (USD Million)
  • 6.4. Static Cold Storage
    • 6.4.1. Static Cold Storage Market, 2018 - 2030 (USD Million)
  • 6.5. Hypothermic Machine Perfusion
    • 6.5.1. Hypothermic Machine Perfusion Market, 2018 - 2030 (USD Million)
  • 6.6. Normothermic Machine Perfusion
    • 6.6.1. Normothermic Machine Perfusion Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Organ Preservation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Organ Preservation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Organ Preservation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Organ Preservation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Organ Preservation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Organ Preservation Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Organ Preservation Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. XVIVO
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. TransMedics, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. 21st Century Medicine
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Bridge to Life Ltd.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Preservation Solutions, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Global Transplant Solutions
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Organ Recovery Systems
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. CryoLife, Inc. (Artivion, Inc)
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Paragonix Technologies, Inc (Getinge)
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦